http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3532048-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e902a0f8946bd4785f06d28f629e834 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-757 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-757 |
| filingDate | 2017-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fcc6eeaf6696bb8a7265c6bb0d97fc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8368824cd98c35ab14409b8ff53fcf9 |
| publicationDate | 2019-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3532048-A1 |
| titleOfInvention | Polysubstituted quinic acid derivatives and use thereof for the treatment of neurodegenerative diseases |
| abstract | The present invention relates to polysubstituted quinic acid derivatives (abbreviated to "PSQs") of general formula (IA): in which R represents a linear or branched, cyclic or branched cyclic, saturated or unsaturated C2-Cp alkyl group, said group being able to be substituted or unsubstituted, p being a natural integer between 3 and 18, and Q1, Q3, Q4 and Q5 each representing, independently of one another, a hydrogen atom or a group selected from caffeoyl, maloyl, caffeoylmaloyl and maloylcaffeoyl groups, with the proviso that at least one of these radicals is not a hydrogen atom, the stereoisomers thereof and the pharmaceutically or nutraceutically acceptable salts thereof, for the prevention and/or the treatment of a neurodegenerative disease, especially Alzheimer's disease. Another subject of the invention is compounds of formula (IA) per se, a process for preparing such compounds, compounds according to the invention intended to be used as medicament, especially for the prevention and/or treatment of a neurodegenerative disease, in particular Alzheimer's disease, and a pharmaceutical composition comprising at least one compound according to the invention. |
| priorityDate | 2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 287.